Sign In

Hannah Chang

Life Sciences Venture Capital

Hannah Chang, M.D., Ph.D. is a prominent figure in the healthcare venture capital industry, combining expertise as a physician, scientist, and investor. She currently serves as the Managing Director at Wu Capital (双湖资本), where she focuses on early-stage biopharmaceutical venture capital investments from the firm's San Francisco office.2

Education and Background

Dr. Chang has an impressive educational background:

  • M.D. from Harvard Medical School
  • Ph.D. in Biophysics from Harvard University
  • B.A. in Chemistry from Princeton University (Summa cum laude)3

She completed clinical training in internal medicine at Beth Israel Deaconess Medical Center and ophthalmology at Massachusetts Eye and Ear Infirmary.1

Professional Experience

  • Managing Director at Wu Capital (July 2017 - Present): Leading healthcare venture capital strategy, investing in innovative biotechnology companies.3
  • Associate at 5AM Ventures (June 2014 - July 2017): Helped found IDEAYA Biosciences (NASDAQ: IDYA) and served as Board Observer for several companies.3
  • Project Leader at The Boston Consulting Group (January 2012 - May 2014): Member of the Healthcare Practice.3

Board Positions

Dr. Chang holds board positions in several companies, including:

  • Ray Therapeutics, Inc.
  • Nuvig Therapeutics Inc.
  • Korro Bio, Inc.
  • IniPharm Pharmaceuticals3

She has also served as a board observer for companies like PACT Pharma, Perfuse Therapeutics, and Akouos.3

Investment Portfolio

Her representative investments include:

  • Semma Therapeutics (acquired by Vertex Pharmaceuticals)
  • Akouos (NASDAQ: AKUS, acquired by Eli Lilly)
  • Korro Bio (NASDAQ: KRRO)
  • Inipharm
  • Gemini Therapeutics12

Dr. Chang's expertise in life sciences venture capital, combined with her medical and scientific background, positions her as a valuable asset in identifying and supporting innovative biotechnology companies with transformative therapeutic potential.1

Highlights

Dec 5 · hbs.edu
Faculty & Advisors | MBA - Harvard Business School
Sep 30 · marketscreener.com
Hannah Chang: Positions, Relations and Network - MarketScreener
Oct 1 · Business Wire
Korro Bio Appoints Omar Khwaja, M.D., Ph.D. to its Board of Directors - Business Wire
Oct 1 · BioSpace
Korro Bio Appoints Omar Khwaja, MD, Ph.D. to its Board of Directors - BioSpace

Related Questions

What are some of the notable investments Hannah Chang has made at Wu Capital?
How did Hannah Chang transition from a clinical career to venture capital?
What is the focus of Wu Capital's investment strategy under Hannah Chang's leadership?
Can you provide more details about Hannah Chang's role at 5AM Ventures?
What are some of the companies Hannah Chang has served on the board of directors for?
Hannah Chang
Hannah Chang, photo 1
Hannah Chang, photo 2
Add to my network

Location

San Francisco Bay Area